278 filings
ARS
2023 FY
FATE
Fate Therapeutics Inc
26 Apr 24
Annual report to shareholders
4:16pm
DEFA14A
FATE
Fate Therapeutics Inc
26 Apr 24
Additional proxy soliciting materials
4:11pm
DEF 14A
FATE
Fate Therapeutics Inc
Definitive proxy
26 Apr 24
4:06pm
S-3
FATE
Fate Therapeutics Inc
Shelf registration
18 Apr 24
4:01pm
PRE 14A
FATE
Fate Therapeutics Inc
Preliminary proxy
16 Apr 24
4:05pm
8-K
9dp2m8
20 Mar 24
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
5:32pm
424B5
fzawn0e
20 Mar 24
Prospectus supplement for primary offering
5:30pm
8-K
dr6 beg1o07eri
26 Feb 24
Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
4:03pm
EFFECT
q18l5jt4g3gj93
28 Nov 23
Notice of effectiveness
12:15am
CORRESP
x05 0en7urffl35hfvgt
21 Nov 23
Correspondence with SEC
12:00am
UPLOAD
hu9 ewljou
15 Nov 23
Letter from SEC
12:00am
8-K
lmv29zm
8 Nov 23
Entry into a Material Definitive Agreement
5:10pm
8-K
54ps 9tsi
8 Nov 23
Fate Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
4:03pm
8-K
shs15qu
1 Sep 23
Other Events
5:29pm
8-K
dlrpd1p2zv2w qwuhnm
8 Aug 23
Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
4:07pm
8-K
uz4jqog4tm09l8 idp
9 Jun 23
Submission of Matters to a Vote of Security Holders
4:08pm